COVID-19 vaccine: DCGI committee recommends use of Biological E’s Corbevax for children between 12 and 18 years

NEW DELHI: The subject experts committee of the Drug Controller General of India (DCGI) has recommended granting emergency use authorisation to Biological E’s Covid vaccine for 12 to 18-year-olds.

The DCGI had on December 28 last year approved Corbevax, which is India’s first indigenous RBD protein sub-unit vaccine, for restricted use in emergency situation in adults. It has not been included in the country’s vaccination drive yet.

The government is yet to take a decision on vaccinating those aged below 15 years.